> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Add Plant-Based Diet Notice to Some Agonists: Petition
- URL: https://www.fdaweb.com/add-plant-based-diet-notice-to-some-agonists-petition/
- Published: 2023-06-21T12:00:00.000Z
- Updated: 2026-09-14T18:40:17.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5154730

The Physicians Committee for Responsible Medicine is petitioning FDA to require that all product packaging and labeling for glucagon-like peptide-1 (GLP-1) receptor agonists disclose that a plant-based diet has an efficacy and safety profile that can be as favorable as, or more favorable than, weight loss drugs. The [petition](https://downloads.regulations.gov/FDA-2023-P-2507-0001/attachment%5F1.pdf?ref=fdaweb.com) provides specific wording the committee recommends be used.

The committee says a “nutritional approach can achieve the same \[weight loss\] goals at reduced risk and for lower cost.” It says that food choices play important roles in the control of appetite and body weight, as well as in the regulation of incretin hormones, particularly GLP-1.